Fetal anemia is a serious complication in pregnancy and associated with perinatal mortality
and morbidity. During 25 years of worldwide experience with intravascular intrauterine blood …

In the space of most paediatricians working lifetime, the spectrum of haemolytic disease of
the newborn (HDN) has changed beyond recognition. Thirty years ago, HDN was almost …

Hemolytic disease of the fetus and newborn (HDFN) affects 3/100 000 to 80/100 000
patients per year. It is due to maternal blood group antibodies that cause fetal red cell …

Objective Maternal alloimmunization to fetal red‐blood‐cell antigens is a major cause of
fetal anemia, which can lead to hydrops and perinatal death if untreated. The cornerstone of …

OBJECTIVE: The purpose of this study was to establish the true procedure-related
complication rate of intrauterine transfusion therapy. STUDY DESIGN: A cohort study of 254 …

OBJECTIVE: To determine the incidence and risk factors for neurodevelopmental
impairment (NDI) in children with hemolytic disease of the fetus/newborn treated with …

Introduction: Hemolytic disease of the fetus and newborn (HDFN) remains a serious
pregnancy complication which can lead to severe fetal anemia, hydrops and perinatal death …

Background Exchange transfusion and phototherapy have traditionally been used to treat
jaundice and avoid the associated neurological complications. Because of the risks and …

Alloimmunization to red blood cell (RBC) antigens represents a challenge for physicians
caring for women of child bearing potential. Exposure to non-self RBC antigens may occur …

Objective In this study, we aim to evaluate trends in the condition of fetuses and neonates
with hemolytic disease at the time of first intrauterine transfusion (IUT) and at birth, in relation …